Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma

PURPOSE: Purpose: Radiation therapy (RT) and the antibody-drug conjugate brentuximab vedotin (BV) are standard-of-care treatment options for patients with certain B and T-cell lymphomas; however, there are limited data exploring the safety of concurrent BV and RT (BVRT). METHODS AND MATERIALS: We pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Susan Y., Fang, Penny Q., Wang, Ethan B., Ahmed, Sairah, Duvic, Madeleine, Jain, Preetesh, Castillo, Luis E. Malpica, Nair, Ranjit, Steiner, Raphael E., Strati, Paolo, Huen, Auris O., Iyer, Swaminathan P., Pinnix, Chelsea C., Dabaja, Bouthaina S., Gunther, Jillian R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336411/
https://www.ncbi.nlm.nih.gov/pubmed/37448588
http://dx.doi.org/10.1016/j.adro.2023.101279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336411/
https://www.ncbi.nlm.nih.gov/pubmed/37448588
http://dx.doi.org/10.1016/j.adro.2023.101279

Ejemplares similares